TY - JOUR T1 - Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis JF - Thorax JO - Thorax SP - 866 LP - 866 DO - 10.1136/thoraxjnl-2012-202848 VL - 68 IS - 9 AU - Rachel Mackley Y1 - 2013/09/01 UR - http://thorax.bmj.com/content/68/9/866.abstract N2 - This randomised, double-blind placebo control trial from New Zealand looked at the use of azithromycin in non-cystic fibrosis bronchiectasis and aimed to assess its effect on exacerbation frequency, lung function and health-related quality of life.The trial enrolled 141 participants and randomly assigned them to receive either azithromycin 500 mg three times a week for 6 months, or placebo, … ER -